Private-equity firms are reportedly in talks to acquire a controlling stake in the domestic formulations business of India’s Wockhardt, which is seeking funds to pay down significant debts.
Private-equity players Apax Partners, Blackstone, Carlyle and KKR are in talks with debt-laden Indian generic drugmaker Wockhardt to buy a “substantial” stake in the company’s domestic formulations business, leading financial daily The Economic Times has reported.
The newspaper, quoting unnamed sources “aware of the discussions,” said the buyout companies were each seeking at least a 51%...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
